Tirzepatide News | Live Feed & Top Stories

Tirzepatide

We only need a few more clicks to be able to show the most read stories for this topic. Take a look at the latest headlines below and help us out by clicking on what you find interesting!

In the last hour

HealthDay19:01

Earlier today

MailOnline10:58

Daily Record09:08

TIME08:34

Verdict Medical Devices07:13

pharmaphorum05:40

Yesterday

Evening Standard14:50 20-Jan-25

The Nittany Turkey (Weblog)14:03 20-Jan-25

Pharmacy Times12:40 20-Jan-25

Yahoo! UK & Ireland12:35 20-Jan-25

TCTMD11:43 20-Jan-25

i News11:14 20-Jan-25

Medpage Today11:01 20-Jan-25

Zacks10:02 20-Jan-25

Hindustan Times08:26 20-Jan-25

The Financial Express08:00 20-Jan-25

The Financial Express03:44 20-Jan-25

The Financial Express03:21 20-Jan-25

In the last 7 days

Metro.co.uk12:29 19-Jan-25

pharmaphorum07:21 19-Jan-25

The Motley Fool04:25 19-Jan-25

The Financial Express22:01 18-Jan-25

The Motley Fool06:43 18-Jan-25

The Motley Fool06:12 18-Jan-25

Medpage Today15:17 17-Jan-25

BioPharma Dive15:12 17-Jan-25

TCTMD15:00 17-Jan-25

The Motley Fool11:39 17-Jan-25

Men's Health10:43 17-Jan-25

Yahoo! US09:48 17-Jan-25

The House of Commons Library blog09:39 17-Jan-25

Yahoo! UK & Ireland06:46 17-Jan-25

Pharmaceutical Technology17:04 16-Jan-25

Patch12:06 16-Jan-25

British Medical Journal11:27 16-Jan-25

The Motley Fool03:24 16-Jan-25

The Korea Herald21:55 15-Jan-25

Benzinga14:42 15-Jan-25

Zacks13:05 15-Jan-25

JD Supra11:52 15-Jan-25

MailOnline11:42 15-Jan-25

Pharmacy Times08:10 15-Jan-25

pharmaphorum08:04 15-Jan-25

Finance in Bold07:43 15-Jan-25

Zacks07:30 15-Jan-25

Pharmaceutical Technology06:40 15-Jan-25

pharmaphorum04:41 15-Jan-25

Scrip Pharma Intelligence21:54 14-Jan-25

Yahoo! UK & Ireland15:19 14-Jan-25

Proactive Investors (US)14:09 14-Jan-25

Yahoo! UK & Ireland14:08 14-Jan-25

Proactive Investors (US)13:18 14-Jan-25

University of Ottawa (Press Release)12:25 14-Jan-25

Quartz11:25 14-Jan-25

Benzinga11:16 14-Jan-25

WSFA TV 12, Alabama10:38 14-Jan-25

NutraIngredients-USA.com10:36 14-Jan-25

Benzinga10:23 14-Jan-25

The List10:10 14-Jan-25

Daily Record10:05 14-Jan-25

Medpage Today09:40 14-Jan-25

PR Newswire (Press Release)08:58 14-Jan-25

Next Avenue07:11 14-Jan-25

In the last month

ABC15.com, Arizona16:30 13-Jan-25

University at Buffalo13:07 13-Jan-25

Pharmacy Times12:46 13-Jan-25

The Nittany Turkey (Weblog)12:04 13-Jan-25

Labiotech09:02 13-Jan-25

GlobeNewswire (Press Release)07:08 13-Jan-25

Regeneron Pharmaceuticals (Press Release)06:37 13-Jan-25

pharmaphorum05:12 13-Jan-25

Pharmaceutical Technology04:31 13-Jan-25

New Zealand Herald21:11 10-Jan-25

European Pharmaceutical Review18:58 10-Jan-25

GlobeNewswire (Press Release)16:16 10-Jan-25

Drug Target Review06:15 10-Jan-25

Community Impact Newspaper16:18 9-Jan-25

TCTMD15:54 9-Jan-25

Benzinga14:16 9-Jan-25

view more headlines

21 Jan 19:01

About our Tirzepatide news

Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.

쮸떴눈첵

Tirzepatide

About our Tirzepatide news

Health Top Stories

Lifestyle Top Stories